Treatment for Livedoid Vasculopathy: A Systematic Review
Sign Up to like & getrecommendations! Published in 2018 at "JAMA Dermatology"
DOI: 10.1001/jamadermatol.2017.4374
Abstract: Importance Livedoid vasculopathy is a painful, ulcerative condition of the lower extremities for which no established treatment exists. Current treatment paradigms rely on low levels of evidence, primarily case reports and case series. Objective To… read more here.
Keywords: livedoid vasculopathy; treatment; systematic review; case ... See more keywords
Intravenous immunoglobulin in resistant livedoid vasculopathy: Analysis of a case series
Sign Up to like & getrecommendations! Published in 2020 at "Dermatologic Therapy"
DOI: 10.1111/dth.13229
Abstract: We report a retrospective analysis the efficacy of high‐dose intravenous immunoglobulins on 9 patients with Livedoid vasculopathy for whom resistant to immunosuppressants plus anticoagulants or could not be prescribed. Intravenous immunoglobulins were used 2 g/kg… read more here.
Keywords: intravenous immunoglobulin; livedoid vasculopathy; resistant livedoid; analysis ... See more keywords
Livedoid vasculopathy and its association with genetic variants: A systematic review
Sign Up to like & getrecommendations! Published in 2021 at "International Wound Journal"
DOI: 10.1111/iwj.13563
Abstract: Livedoid vasculopathy (LV) is considered a disease of hypercoagulability. Association of LV with genetic variants is poorly characterised and large‐scale genetic association studies have not been performed. The aim of the study was to systematically… read more here.
Keywords: livedoid vasculopathy; genetic variants; association; review ... See more keywords
Characteristics, risk factors and treatment reality in livedoid vasculopathy – a multicentre analysis
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.15639
Abstract: Livedoid vasculopathy (LV) is a rare cutaneous thrombotic disease. It is characterized by occlusion of dermal vessels resulting in livedo racemosa, ulceration and atrophie blanche. Clear guidelines for diagnosis and treatment are missing. read more here.
Keywords: livedoid vasculopathy; treatment; characteristics risk; risk factors ... See more keywords
Remission of long-standing livedoid vasculopathy using a whole foods plant-based diet with symptoms recurrent on re-challenge with standard Western diet
Sign Up to like & getrecommendations! Published in 2021 at "BMJ Case Reports"
DOI: 10.1136/bcr-2020-237895
Abstract: A 63-year-old woman presented with ulcerations of both lower legs. Symptom onset was 2006. In 2013 she saw a dermatologist and a biopsy suggested livedoid vasculopathy. In 2016 a whole food plant-based diet (WFPB) was… read more here.
Keywords: remission long; livedoid vasculopathy; plant based; based diet ... See more keywords
Efficacy and safety of intravenous immunoglobulin for treating refractory livedoid vasculopathy: a systematic review
Sign Up to like & getrecommendations! Published in 2022 at "Therapeutic Advances in Chronic Disease"
DOI: 10.1177/20406223221097331
Abstract: Introduction: Intravenous immunoglobulin (IVIG) was reported to be the third most used monotherapy in livedoid vasculopathy (LV). There is currently a lack of randomized controlled clinical trials and no standardized therapeutic regimen for IVIG therapy… read more here.
Keywords: systematic review; efficacy safety; intravenous immunoglobulin; ivig therapy ... See more keywords
Baricitinib is potentially effective in the treatment of refractory livedoid vasculopathy
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.1008392
Abstract: Background Livedoid vasculopathy is a rare, chronic, and recurrent disease with limited effective treatments. Its etiopathogenesis remains incompletely understood. Baricitinib, a selective Janus kinase 1 and 2 inhibitor, has been used to treat rheumatoid arthritis… read more here.
Keywords: refractory livedoid; treatment refractory; baricitinib treatment; treatment ... See more keywords
Adalimumab in Treating Refractory Livedoid Vasculopathy
Sign Up to like & getrecommendations! Published in 2022 at "Vaccines"
DOI: 10.3390/vaccines10040549
Abstract: Livedoid vasculopathy is a chronic, recurrent skin disorder. It seriously affects the quality of patients’ life. However, the pathogenesis has not been fully identified yet. Here, this retrospective study describes the successful use of anti-TNF-α… read more here.
Keywords: treating refractory; adalimumab treating; refractory livedoid; livedoid vasculopathy ... See more keywords